• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Omeros Corporation - Common Stock (NQ:OMER)

9.790 -0.460 (-4.49%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,717,309
Open 10.23
Bid (Size) 9.830 (400)
Ask (Size) 10.03 (100)
Prev. Close 10.25
Today's Range 9.750 - 10.26
52wk Range 2.950 - 17.65
Shares Outstanding 62,855,824
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Omeros (OMER) Q4 2025 Earnings Transcript ↗
June 01, 2026
Omeros (OMER) Q4 2025 Earnings Transcript 
Via The Motley Fool
Topics Derivatives
News headline image
Omeros (OMER) Q1 2026 Earnings Transcript ↗
May 14, 2026
Omeros (OMER) Q1 2026 Earnings Transcript 
Via The Motley Fool

Performance

YTD
-40.2%
-40.2%
1 Month
-34.0%
-34.0%
3 Month
-15.2%
-15.2%
6 Month
-9.8%
-9.8%
1 Year
+196.7%
+196.7%

More News

Read More
News headline image
Omeros Q1 Earnings Call Highlights ↗
May 14, 2026
Via MarketBeat
Topics Earnings
Omeros Corp (NASDAQ:OMER) Swings to Profit on YARTEMLEA Launch, Topping EPS Forecasts ↗
May 13, 2026
Via Chartmill
Omeros Corp (NASDAQ:OMER) Reports Q4 2025 Earnings Boosted by Major Asset Sale, Launches First Commercial Product ↗
March 31, 2026
Via Chartmill
News headline image
Omeros Corporation Reports First Quarter 2026 Financial Results
May 13, 2026
From Omeros Corporation
Via Business Wire
News headline image
Omeros Corporation to Announce First Quarter Financial Results on May 13, 2026
May 11, 2026
From Omeros Corporation
Via Business Wire
News headline image
Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer
April 20, 2026
From Sagimet Biosciences Inc.
Via GlobeNewswire
News headline image
CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA® (narsoplimab-wuug)
April 16, 2026
From Omeros Corporation
Via Business Wire
These stocks are gapping in today's session ↗
April 01, 2026
Via Chartmill
News headline image
Omeros Corporation Reports Fourth Quarter and Year-End 2025 Financial Results
March 31, 2026
From Omeros Corporation
Via Business Wire
News headline image
Omeros Corporation to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 31, 2026
March 26, 2026
From Omeros Corporation
Via Business Wire
News headline image
Omeros Announces Upcoming Presentation at EBMT 2026 Highlighting Advances in TA-TMA Treatment
March 21, 2026
From Omeros Corporation
Via Business Wire
News headline image
Omeros Announces Successful Primate Study in OncotoX-AML™ Drug Program
February 17, 2026
From Omeros Corporation
Via Business Wire
News headline image
Omeros Announces First Commercial Sales of YARTEMLEA®
January 27, 2026
From Omeros Corporation
Via Business Wire
News headline image
Nasdaq, S&P 500 Futures Dip As Investors Brace For Jobs Data, Tariff Ruling: Why NVDA, MSFT, AAPL, APLD, NIO Are On Traders' Radar Today ↗
January 08, 2026
Via Stocktwits
Topics ETFs Government Stocks
News headline image
Why Did Omeros Stock Jump 5% In After-Hours Trading Today? ↗
January 07, 2026
Via Stocktwits
News headline image
Omeros Announces New Date for YARTEMLEA® Approval Conference Call
December 26, 2025
From Omeros Corporation
Via Business Wire
News headline image
Why Omeros Stock Skyrocketed Today ↗
December 24, 2025
Via The Motley Fool
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
December 24, 2025
Via Chartmill
News headline image
Retail’s Christmas Eve Watchlist: Omeros, Nike, Citi, Dynavax And Agios Spark Most Market Chatter ↗
December 24, 2025
Via Stocktwits
Topics ETFs Economy Stocks
News headline image
Top movers in Wednesday's session ↗
December 24, 2025
Via Chartmill
News headline image
Which stocks are gapping on Wednesday? ↗
December 24, 2025
Via Chartmill
News headline image
Omeros Stock Jumps Premarket After FDA Approves First Drug For Rare Transplant Complication — Retail Sees Big Upside ↗
December 24, 2025
Via Stocktwits
News headline image
FDA Approves Omeros’ YARTEMLEA® – First and Only Therapy Indicated for TA-TMA
December 24, 2025
From Omeros Corporation
Via Business Wire

Frequently Asked Questions

Is Omeros Corporation - Common Stock publicly traded?
Yes, Omeros Corporation - Common Stock is publicly traded.
What exchange does Omeros Corporation - Common Stock trade on?
Omeros Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Omeros Corporation - Common Stock?
The ticker symbol for Omeros Corporation - Common Stock is OMER on the Nasdaq Stock Market
What is the current price of Omeros Corporation - Common Stock?
The current price of Omeros Corporation - Common Stock is 9.790
When was Omeros Corporation - Common Stock last traded?
The last trade of Omeros Corporation - Common Stock was at 06/05/26 04:00 PM ET
What is the market capitalization of Omeros Corporation - Common Stock?
The market capitalization of Omeros Corporation - Common Stock is 615.36M
How many shares of Omeros Corporation - Common Stock are outstanding?
Omeros Corporation - Common Stock has 615M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap